1. Home
  2. CTSO vs ACCL Comparison

CTSO vs ACCL Comparison

Compare CTSO & ACCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

HOLD

Current Price

$0.81

Market Cap

45.7M

Sector

Health Care

ML Signal

HOLD

ACCL

Acco Group Holdings Limited Ordinary Shares

N/A

Current Price

$1.48

Market Cap

20.2M

ML Signal

N/A

Company Overview

Basic Information
Metric
CTSO
ACCL
Founded
1997
2009
Country
United States
Hong Kong
Employees
N/A
22
Industry
Medical/Dental Instruments
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
45.7M
20.2M
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
CTSO
ACCL
Price
$0.81
$1.48
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$5.38
N/A
AVG Volume (30 Days)
69.2K
62.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$22,503,908.00
N/A
Revenue This Year
$7.29
N/A
Revenue Next Year
$8.91
N/A
P/E Ratio
N/A
$17.13
Revenue Growth
48.53
N/A
52 Week Low
$0.60
$1.23
52 Week High
$1.39
$5.00

Technical Indicators

Market Signals
Indicator
CTSO
ACCL
Relative Strength Index (RSI) 71.21 38.44
Support Level $0.62 $1.29
Resistance Level $0.85 $1.69
Average True Range (ATR) 0.04 0.10
MACD 0.02 0.06
Stochastic Oscillator 84.73 55.27

Price Performance

Historical Comparison
CTSO
ACCL

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

About ACCL Acco Group Holdings Limited Ordinary Shares

Acco Group Holdings Ltd is a holding company. Through its Operating Subsidiaries, it is a multi-disciplinary, IT-driven corporate service provider with a presence in Hong Kong and Singapore. Under the Accolade brand, it specializes in offering corporate secretarial services and accounting services in Hong Kong, as well as intellectual properties (IP) registration services in Singapore. Leveraging developed IT solutions, It provides comprehensive, reliable and professional support to its clients, enabling them to focus on their core business activities while it manages and handles their corporate compliance needs. Its clientele ranges from individual clients, small and medium-sized enterprises to multinational corporations, reflecting its ability to cater to diverse business needs.

Share on Social Networks: